Cognex Corporation $CGNX Shares Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership lifted its position in shares of Cognex Corporation (NASDAQ:CGNXFree Report) by 115.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,033,091 shares of the scientific and technical instruments company’s stock after acquiring an additional 1,090,092 shares during the period. Arrowstreet Capital Limited Partnership owned about 1.22% of Cognex worth $99,601,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CGNX. State of Michigan Retirement System boosted its holdings in shares of Cognex by 0.5% in the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock valued at $1,952,000 after buying an additional 200 shares during the period. Personal CFO Solutions LLC boosted its stake in Cognex by 3.2% in the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company’s stock valued at $333,000 after acquiring an additional 212 shares during the period. World Investment Advisors grew its holdings in shares of Cognex by 3.7% during the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company’s stock valued at $298,000 after purchasing an additional 214 shares during the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Cognex by 1.0% during the fourth quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after purchasing an additional 234 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in shares of Cognex by 12.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock valued at $68,000 after purchasing an additional 243 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Trading Down 2.2%

Shares of NASDAQ CGNX opened at $62.05 on Friday. Cognex Corporation has a 12-month low of $33.45 and a 12-month high of $72.88. The company has a market cap of $10.33 billion, a PE ratio of 73.87 and a beta of 1.49. The stock has a 50 day simple moving average of $64.97 and a 200-day simple moving average of $55.34.

Cognex (NASDAQ:CGNXGet Free Report) last posted its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm had revenue of $268.44 million for the quarter, compared to analysts’ expectations of $245.98 million. During the same period last year, the firm earned $0.14 EPS. The firm’s revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Sell-side analysts forecast that Cognex Corporation will post 1.48 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 4th. Investors of record on Thursday, May 21st were paid a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 21st. Cognex’s payout ratio is currently 40.48%.

Analyst Ratings Changes

CGNX has been the topic of several recent research reports. JPMorgan Chase & Co. raised Cognex from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $65.00 to $75.00 in a report on Tuesday, May 26th. Truist Financial upped their price objective on Cognex from $61.00 to $71.00 and gave the stock a “hold” rating in a research note on Thursday, July 2nd. Barclays reaffirmed an “overweight” rating and issued a $75.00 target price (up from $64.00) on shares of Cognex in a research report on Monday, May 11th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $75.00 target price on shares of Cognex in a research note on Thursday, May 7th. Finally, Citigroup reissued a “neutral” rating and set a $72.00 price target (up from $68.00) on shares of Cognex in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $72.31.

Check Out Our Latest Research Report on CGNX

Insider Activity at Cognex

In other Cognex news, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the transaction, the insider owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. This trade represents a 85.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darren Marc Long sold 20,252 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares in the company, valued at approximately $264,696.60. The trade was a 83.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 224,847 shares of company stock worth $14,975,098 over the last ninety days. 1.70% of the stock is currently owned by corporate insiders.

About Cognex

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Read More

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.